Drug Profile


Alternative Names: emoxipin

Latest Information Update: 31 Oct 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Class Antidementias; Anxiolytics; Neuroprotectants; Picolines; Small molecules
  • Mechanism of Action Antioxidants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Anxiety disorders; Cognition disorders; Ischaemic heart disorders; Pancreatitis; Peptic ulcer

Most Recent Events

  • 05 Dec 2000 A study has been added to the Peptic Ulcer Disease therapeutic trials section
  • 04 Dec 2000 Investigation in Peptic ulcer in Russia (Unknown route)
  • 04 Dec 2000 Preclinical development for Pancreatitis in Russia (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top